Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial.

Journal article

PURPOSE: We determined the clinical efficacy and safety of terazosin in the treatment of patients with female lower urinary tract symptoms. MATERIALS AND METHODS: A total of 100 females 20 to 70 years old who met the inclusion criteria of total International Prostate Symptom Score 8 or greater, symptom duration 1 or more months, and did not meet any exclusion criteria were entered into the study. Subjects were randomized to receive terazosin or placebo in titrated dose from 1 mg od, 1 mg twi...

Expand abstract

Authors: Low, B; Liong, M; Yuen, K; Chee, C; Leong, W

• Publication status: Published
• Journal: Journal of urology
• Volume: 179
• Issue: 4
• Pages: 1461-1469
• Publication date: 2008-04-01
• DOI: 10.1016/j.juro.2007.11.060
• EISSN: 1527-3792
• ISSN: 0022-5347
• Language: English
• Keywords: Middle Aged; Urination Disorders; Adult; Humans; Prazosin; Aged; Double-Blind Method; Female; Adrenergic alpha-Antagonists